$Sarepta Therapeutics(SRPT.US)$ SO THIS IS WHY ? Last quarter they raised the 2021 guidance to 605-615M and the slide in the presentation shows 612M unaudited annual revenue. $2.1B in cash. There is absolutely no reason the stock to sell off 12%, it is exactly what they guided , this is absolutely the best buying opportunity in the biotech sector period. Sarepta should be trading at $15B not pathetic 6.5B !
2021 Guidance Raised
Sarepta raised its guidance for revenue...

$Lumentum(LITE.US)$ anyone notice the volume yesterday?

$Onconova Therapeutics Inc(ONTX.US)$ email to CEO to RESIGN SFRUCHTMAN@ONCONOVA.US ir@onconova.us this pattern of investors dilution has to STOP 🛑

$Onconova Therapeutics Inc(ONTX.US)$ email CEO SFRUCHTMAN@ONCONOVA.US to resign. we need new management.

$Onconova Therapeutics Inc(ONTX.US)$ this company market cap is way too low it is run by James Marino who brought celtex from 34 cents to $50 it will do the same with Onconova. trillium sold for 2 billion ! $Biocept Inc(BIOC.US)$ is another top takeover candidate , micro cap at this point

$Biocept Inc(BIOC.US)$ the market cap of 50M is way too undervalued. $Exact Sciences(EXAS.US)$ will buy this company

$La Jolla Pharmaceutical Co(LJPC.US)$ should have much higher market cap !